TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Biobasiq Sverige AB
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
26,746
|
17,078
|
15,688 |
| Financial expenses |
46
|
55
|
76 |
| Earnings before taxes |
74
|
1,002
|
1,718 |
| EBITDA |
67
|
1,058
|
1,794 |
| Total assets |
8,004
|
6,960
|
5,866 |
| Current assets |
8,004
|
6,960
|
5,866 |
| Current liabilities |
2,582
|
1,949
|
1,518 |
| Equity capital |
5,422
|
5,011
|
4,348 |
| - share capital |
101
|
95
|
98 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
67.7%
|
72.0%
|
74.1% |
| Turnover per employee |
13,373
|
8,539
|
7,844 |
| Profit as a percentage of turnover |
0.3%
|
5.9%
|
11.0% |
| Return on assets (ROA) |
1.5%
|
15.2%
|
30.6% |
| Current ratio |
310.0%
|
357.1%
|
386.4% |
| Return on equity (ROE) |
1.4%
|
20.0%
|
39.5% |
| Change turnover |
8,457
|
1,861
|
1,713 |
| Change turnover % |
46%
|
12%
|
12% |
| Chg. No. of employees |
0
|
0
|
-1 |
| Chg. No. of employees % |
0%
|
0%
|
-33% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.